Martha Morrell - 20 Aug 2025 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Leah Akin, Attorney-in-Fact
Issuer symbol
NPCE
Transactions as of
20 Aug 2025
Net transactions value
-$26,430
Form type
4
Filing time
22 Aug 2025, 16:15:05 UTC
Previous filing
06 Jun 2025
Next filing
28 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morrell Martha CHIEF MEDICAL OFFICER C/O NEUROPACE INC., 455 N. BERNARDO AVENUE, MOUNTAIN VIEW /s/ Leah Akin, Attorney-in-Fact 22 Aug 2025 0001855616

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Tax liability $26,430 -3,052 -3.5% $8.66 85,174 20 Aug 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer on August 20, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.
F2 Includes 2,283 shares acquired pursuant to the NeuroPace, Inc. 2021 Employee Stock Purchase Plan.